[go: up one dir, main page]

AU2001286861A1 - Use of methylphenidate compounds to enhance memory - Google Patents

Use of methylphenidate compounds to enhance memory

Info

Publication number
AU2001286861A1
AU2001286861A1 AU2001286861A AU8686101A AU2001286861A1 AU 2001286861 A1 AU2001286861 A1 AU 2001286861A1 AU 2001286861 A AU2001286861 A AU 2001286861A AU 8686101 A AU8686101 A AU 8686101A AU 2001286861 A1 AU2001286861 A1 AU 2001286861A1
Authority
AU
Australia
Prior art keywords
enhance memory
methylphenidate compounds
methylphenidate
compounds
enhance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001286861A
Other languages
English (en)
Inventor
Mel H. Epstein
Kjesten A. Wiig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sention Inc
Original Assignee
Sention Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sention Inc filed Critical Sention Inc
Publication of AU2001286861A1 publication Critical patent/AU2001286861A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AU2001286861A 2000-08-28 2001-08-28 Use of methylphenidate compounds to enhance memory Abandoned AU2001286861A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US22852500P 2000-08-28 2000-08-28
US60/228,525 2000-08-28
US23597100P 2000-09-28 2000-09-28
US60/235,971 2000-09-28
US24827800P 2000-11-14 2000-11-14
US60/248,278 2000-11-14
PCT/US2001/026829 WO2002017920A2 (fr) 2000-08-28 2001-08-28 Utilisation de composes de methylphenidate pour renforcer la memoire

Publications (1)

Publication Number Publication Date
AU2001286861A1 true AU2001286861A1 (en) 2002-03-13

Family

ID=27397856

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001286861A Abandoned AU2001286861A1 (en) 2000-08-28 2001-08-28 Use of methylphenidate compounds to enhance memory

Country Status (3)

Country Link
US (1) US20030229122A1 (fr)
AU (1) AU2001286861A1 (fr)
WO (1) WO2002017920A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002243451A1 (en) * 2001-01-02 2002-07-16 Sention, Inc. Use of catecholamine reuptake inhibitors to enhance memory
US8653106B2 (en) * 2010-07-30 2014-02-18 Pisgah Laboratories, Inc. Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
US20190329063A1 (en) * 2016-12-25 2019-10-31 The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center Method for modifying the therapeutic effects of drugs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922736A (en) * 1995-12-04 1999-07-13 Celegene Corporation Chronic, bolus administration of D-threo methylphenidate
GB9711032D0 (en) * 1997-05-30 1997-07-23 Johnson Matthey Plc Compound as a stimulant for the central nervous system
DE19906975B4 (de) * 1999-02-19 2004-04-15 Lts Lohmann Therapie-Systeme Ag Arzneiform zur Behandlung von Alzheimer'scher Demenz
US6025502A (en) * 1999-03-19 2000-02-15 The Trustees Of The University Of Pennsylvania Enantopselective synthesis of methyl phenidate

Also Published As

Publication number Publication date
WO2002017920A3 (fr) 2003-01-23
WO2002017920A2 (fr) 2002-03-07
US20030229122A1 (en) 2003-12-11

Similar Documents

Publication Publication Date Title
TWI318201B (en) Novel succinate salt of o-desmethyl-venlafaxine
GB0025782D0 (en) Use of inhibitors
AU2001285325A1 (en) Use of threo-methylphenidate compounds to enhance memory
AU2002217071A1 (en) Novel use of polyhydroxy compounds
AU2001255090A1 (en) Cdk inhibitors having 3-hydroxychromen-4-one structure
TW444674U (en) Improved structure of ornament
AU2002219175A1 (en) Crystalline forms of cerivastatin sodium
AU2001241037A1 (en) Use of piperidine benzoderivatives as fungicides
GB0023289D0 (en) Determination of displacement
AU2001286861A1 (en) Use of methylphenidate compounds to enhance memory
EP1215193A3 (fr) Préparation d'acrylates de 2-hydrocarbyle-2-adamantyle
AU2001290731A1 (en) Structural prediction of allosterism
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines
AU2001233246A1 (en) Novel use of ribozymes to block gene expression
AU2001249683A1 (en) Synthesis of thiazolium compounds
AU2002216038A1 (en) Preparation of monofluoroalkenes
AU2001259381A1 (en) Synthesis of diphosphinoarenes
TW463577U (en) Improved structure of high-heels shoes
TW465685U (en) Structure of nail
TW480914U (en) Improved structure of fishpot
TW432952U (en) Improved structure of lunch-box
HK1059620A (en) Crystalline forms of atorvastatin
PL340617A1 (en) Derivatives of 2-acylpyridine
AUPR183500A0 (en) Synthesis of cyclic compounds
TW491398U (en) Improved structure of tip-discharging capacitor